Comparison of Two Respiratory Physiotherapy Treatments in Postcovid-19 Patients.

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 21, 2022

Study Completion Date

August 24, 2022

Conditions
COVID-19Respiratory Distress Syndrome
Interventions
DEVICE

PowerBreathe and PEP Therosold tools

"Initially, the following data were collected from each subject in addition to basic epidemiological data:~M-mode diaphragmatic excursion measurements, both in inspiration and expiration via ultrasound; spirometry is also carried out, obtaining values of forced vital capacity (FVC or FVC), forced expiratory volume (FEV), portion of FVC (FEV1/FVC), peak expiratory flow (PEF), mean expiratory flow, peak inspiratory pressure (PIM) and peak expiratory pressure (PEM). A 30-day treatment plan was carried out in which one group (Tool Group) had to perform 5 minutes of exercise with each tool, alternating with one minute of rest between each minute of exercise, starting with the Therosold PEP® and then the PowerBreathe®. The resistances applied to the devices were marked according to the specific assessment of each subject, in relation to the spirometric values of PIM and PEM."

Trial Locations (1)

05005

Universidad Católica de Ávila, Ávila

All Listed Sponsors
lead

Universidad Católica de Ávila

OTHER